Publication:
Average Visits per Month:
In Numbers:
Testimonials:
|
Pharmaceutical Technology |
5,800 |
|
Pharmaceutical Executive |
4,500 |
|
NG Pharma EU |
24,000 |
|
Contract Pharma |
6,400 |
There isn’t another publication out there that deals with the most topical issues in pharma as conscientiously and thought provoking as Next Generation Pharma.
Keith Blundy Board Member, Cancer Research Technologye
NGP consistently delivers a standout resource for the industry. Well done to all involved.
Reinhold Gahlmann Managing Director & Head of Drug Development, Biofrontera Bioscience GmbH